{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:10:19Z","timestamp":1776085819211,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T00:00:00Z","timestamp":1718496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS081054"],"award-info":[{"award-number":["R01NS081054"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.neurot.2024.e00389","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T13:35:12Z","timestamp":1719581712000},"page":"e00389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unlock the potential: Auditory-evoked event-related potential (ERP) as a treatment-responsive biomarker for Rett syndrome"],"prefix":"10.1016","volume":"21","author":[{"given":"Joanna","family":"Medina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaolan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neurot.2024.e00389_bib1","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neurot.2024.e00389_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2022.106704","article-title":"Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome","volume":"114","author":"Neul","year":"2022","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.neurot.2024.e00389_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fnint.2020.00030","article-title":"Evoked potentials and EEG analysis in Rett syndrome and related developmental encephalopathies: towards a biomarker for translational research","volume":"14","author":"Saby","year":"2020","journal-title":"Front Integr Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00389_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrn2774","article-title":"Abnormal neural oscillations and synchrony in schizophrenia","volume":"11","author":"Uhlhaas","year":"2010","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00389_bib5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nn.2997","article-title":"Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses","volume":"15","author":"Goffin","year":"2011","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00389_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0387-7604(89)80078-6","article-title":"Neurophysiological findings in the Rett syndrome, II: visual and auditory brainstem, middle and late evoked responses","volume":"11","author":"Bader","year":"1989","journal-title":"Brain Dev"},{"issue":"8","key":"10.1016\/j.neurot.2024.e00389_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.braindev.2006.02.011","article-title":"The development of visual- and auditory processing in Rett syndrome: an ERP study","volume":"28","author":"Stauder","year":"2006","journal-title":"Brain Dev"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00389_bib8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ana.26029","article-title":"Multisite study of evoked potentials in Rett syndrome","volume":"89","author":"Saby","year":"2021","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00389_bib9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24513","article-title":"Visual evoked potentials detect cortical processing deficits in Rett syndrome","volume":"78","author":"LeBlanc","year":"2015","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00389_bib10","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.neuron.2012.12.004","article-title":"NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2","volume":"76","author":"Durand","year":"2012","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00389_bib11","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nn.3710","article-title":"Cellular origins of auditory event-related potential deficits in Rett syndrome","volume":"17","author":"Goffin","year":"2014","journal-title":"Nat Neurosci"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00389_bib12","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1172\/JCI90967","article-title":"Elevating expression of MeCP2 T158M rescues DNA binding and Rett syndrome-like phenotypes","volume":"127","author":"Lamonica","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.neurot.2024.e00389_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105083","article-title":"Detection of neurophysiological features in female R255X MeCP2 mutation mice","volume":"145","author":"Dong","year":"2020","journal-title":"Neurobiol Dis"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00389_bib14","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1007\/s13311-022-01254-3","article-title":"Clinical and preclinical evidence for M(1) muscarinic acetylcholine receptor potentiation as a therapeutic approach for Rett syndrome","volume":"19","author":"Smith","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2024.e00389_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00384","article-title":"Potentiation of the muscarinic acetylcholine receptor 1 modulates neurophysiological features in a mouse model of Rett syndrome","author":"Dong","year":"2024","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00389_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s11689-023-09479-9","article-title":"Comparison of evoked potentials across four related developmental encephalopathies","volume":"15","author":"Saby","year":"2023","journal-title":"J\u00a0Neurodev Disord"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00389_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac197","article-title":"Electrophysiological biomarkers of brain function in CDKL5 deficiency disorder","volume":"4","author":"Saby","year":"2022","journal-title":"Brain Commun"},{"issue":"20","key":"10.1016\/j.neurot.2024.e00389_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143655","article-title":"Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder-related deficits","volume":"131","author":"Terzic","year":"2021","journal-title":"J\u00a0Clin Invest"},{"issue":"52","key":"10.1016\/j.neurot.2024.e00389_bib19","doi-asserted-by":"crossref","first-page":"21516","DOI":"10.1073\/pnas.1216988110","article-title":"Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice","volume":"109","author":"Wang","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.neurot.2024.e00389_bib20","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.biopsych.2010.09.031","article-title":"Validating gamma oscillations and delayed auditory responses as translational biomarkers of autism","volume":"68","author":"Gandal","year":"2010","journal-title":"Biol Psychiatr"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00389_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/aur.111","article-title":"MEG detection of delayed auditory evoked responses in autism spectrum disorders: towards an imaging biomarker for autism","volume":"3","author":"Roberts","year":"2010","journal-title":"Autism Res"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00389_bib22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41398-022-02224-1","article-title":"Neurexin1\u03b1 knockout rats display oscillatory abnormalities and sensory processing deficits back-translating key endophenotypes of psychiatric disorders","volume":"12","author":"Janz","year":"2022","journal-title":"Transl Psychiatry"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924000758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924000758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T04:15:50Z","timestamp":1728274550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747924000758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1878747924000758"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00389","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unlock the potential: Auditory-evoked event-related potential (ERP) as a treatment-responsive biomarker for Rett syndrome","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00389"}}